Influence of Market Access Conditions on Utilization of Innovative Drugs in Europe: Example of Bevacizumab.M. Toumi,J. Misset,L. Krukowski,S. Aballea,M. LamureJOURNAL OF CLINICAL ONCOLOGY(2010)引用 0|浏览33AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要